Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rcrystal
    Junior Member
    • Feb 2012
    • 6

    #1

    Help with experiment analysis- comparison of RNASeq and 3' DGE NuGEN reads

    Using a de-novo transcriptome assembled with Trinity, we are looking at differentially expressed genes between a control tissue and a tissue-of-interest in a spider.

    Specifically, we are comparing the differentially expressed genes identified using Illumina paired RNASeq reads versus NuGen single 3' DGE System reads.

    Currently, I am using Bowtie to map reads from each library type to the reference transcriptome and then using DESeq2 on the resulting raw counts to calculate differentially expressed genes.

    Here is the experimental set up and the problem: we have 2 biological replicates for the tissue of interest for each of the read library types (Illumina and NuGen), but we only have biological replicates for the control tissue for NuGen reads. For the Illumina control reads, we only have one sample.

    My problem is that because the Illumina analysis only has replicates for the tissue of interest and not the control, I'm not convinced I should use the statistical significance results from DESeq2. My limited understanding is that when there are experimental conditions where one has replicates and the other does not, DESeq2 calculates variance from the biological replicates that exist. However, it seems more reasonable to me to write the results based on abundance counts only and not the p-values.

    So, two questions: 1. Should I ignore the p-values from DESeq2 because of my lack of control replicates in one of my analyses? and 2. Can I use the DESeq2 counts of log2fold change to compare the differentially expressed genes between by two library types?

    Thanks very much for your time and help!
  • cmbetts
    Senior Member
    • Jun 2012
    • 120

    #2
    I would be very careful doing differential expression between standard RNA-Seq and 3' libraries. For the standard RNA-Seq, counts should be proportional to transcript length, while a 3' library should have only one count per transcript regardless of length. When comparing similar library types, the various length effects (and other inherent library biases to every construction protocol) effectively cancel out. Here, I'd be afraid your deferentially expression genes will likely reflect the library protocols rather than biology.

    Comment

    • rcrystal
      Junior Member
      • Feb 2012
      • 6

      #3
      Thanks for the reply, cmbetts!

      We're interested in documenting the differences in methodologies you're describing because we want to be aware of all of the caveats present using 3' DGE methods in our system.

      Sorry for a potentially naive request, but do you have any citations for the differences in results between library preparations that you're mentioning? That would be really helpful!

      Comment

      • rcrystal
        Junior Member
        • Feb 2012
        • 6

        #4
        I also want to clarify, in case it's unclear.
        The experiment is set up like this:

        Illumina RNASeq tissue of interest vs. Illumina RNASeq control tissue= RNASeq differentially expressed genes

        NuGen 3' DGE tissue of interest vs. NuGen 3' DGE control tissue = NuGen differentially expressed genes

        We want to compare/contrast the RNASeq differentially expressed genes and NuGen differentially expressed genes.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        32 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...